ReCODE Report delivers personalized information that helps prevent and reverse cognitive decline
The One-time ReCODE Report delivers optimal personalized medical information that allows users and practitioners to achieve unprecedented success in the prevention and reversal of cognitive decline. The report is best for individuals without symptoms or someone interested in checking their risk factors to getting Alzheimer’s disease. It is a highly individualized evaluation of your cognitive health — an assessment based on lab results analyzed by a software program created by Dr. Dale Bredesen and his team at Apollo Health. The report includes information on an individual’s Alzheimer’s subtype, supplemental information of Dr. Bredesen’s research, nutritional instruction, hormonal support, and more.
ReCODE is currently available in the U.S. for $1,245, which includes all necessary assessments, mobile blood draw, blood labs, and genome tests. More information and the complete downloadable ReCODE Test Panel list is available here. *Due to regulatory restrictions, a mobile blood draw option is not available in the following seven states: Rhode Island, New York, Pennsylvania, California, Alaska, Hawaii, or Maryland, individuals from these states will need to purchase a scheduled walk-in blood draw and will receive a discounted rate of $1,090. In an effort to bring you the lowest possible pricing on the ReCODE blood panel, we have extended our lab costs to you — Apollo Health does not make a profit from the labs. This one-time report provides limited access to an Apollo Health Trained Practitioner Locator Tool, which identifies the nearest ReCODE Protocol certified practitioners and coaches. ReVERSE Program subscribers have full access to this locator tool, which allows for the digital sharing of information and direct access to the practitioners and coaches. For further questions, contact us at email@example.com. Those located outside of the U.S. may sign up for our ReVERSE Program.
Identify the specific subtypes and source of your cognitive decline.
Access (limited) to a directory of ReCODE trained practitioners, and coaches.
Check for the ApoE4 gene type (Genome test)
Advise on supplements individually recommended for the subtypes of cognitive decline found in ReCODE Report results (list provided).
The ReCODE engine generates a report for you and your physician. We have created a new category of medical information and analysis where we take highly complex sets of biometric and genetic data sets to generate medical information and a simple image of YOU for you and your physician.
Partnering with Dr. Dale Bredesen, Alzheimer’s research pioneer and inventor of the ReCODE protocol), Apollo Health has created the first software product that identifies subtypes of cognitive decline (types 1-3 Alzheimer’s disease, published by Dr. Bredesen). The software generates optimal personalized medical information that allows users and practitioners to achieve unprecedented success in the prevention and reversal of cognitive decline.
All ReCODE Protocol and Bredesen Protocol assessments and initial treatment suggestions must start with a ReCODE Report. Apollo Health highly recommends consulting with a qualified ReCODE Certified practitioner before beginning the protocol. The ReCODE Protocol is a process that may require three months to a year of treatment and lifestyle changes to show initial improvement or reversal. Treatment must continue to maintain an effective reversal of cognitive decline and continued improvement.
Find a practitioner certified in Dr. Bredesen’s protocol near you.
With both ReVERSE and ReCODE, you’ll identify the subtypes and the sources of your cognitive decline – and be empowered to slow and prevent it.
ReCODE is the first to report the reversal of cognitive decline in patients with early Alzheimer’s disease. Includes all metabolic and genetic laboratory assessment to generate a personalized ReCODE Report.
ReCODE Protocol is based on the breakthrough findings of Dr. Dale Bredesen, a world-renowned leader in Alzheimer’s disease research and a New York Times Best-Selling author.
Where to Begin
The ReCODE Report is the first step to all ReCODE and Bredesen Protocol treatments. Review your results with a certified practitioner and begin your journey to health.
Dale Bredesen, MD
An internationally-recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible. Thanks to a dedicated pursuit of finding the science that makes this a reality, his idea has placed Dr. Bredesen at the vanguard of neurological research, and led to the discoveries that today underlie the ReCode Report.
The End of Alzheimer’s
In his book The End of Alzheimer’s, Dr. Bredesen unveils his groundbreaking protocol to prevent and reverse Alzheimer’s disease. The Bredesen Protocol, known as ReCODE, fundamentally changes how we understand cognitive decline.